Oramed Pharmaceuticals Inc.
Oramed Pharmaceuticals Inc. scores highest on Price (92) and lowest on Earnings (49). Its PosiPenta is 74.51 out of 100, better than most similar companies.
On the Penta Grid this week, Oramed Pharmaceuticals Inc. is Grid #3 of 837 in the Healthcare sector in United States, and Grid #10 of 4,000 in United States.
Compared with similar companies in the Healthcare sector in United States.
The five pillars
Similar companies
| Company | PosiPenta | P | E | N | T | A |
|---|---|---|---|---|---|---|
| Oramed Pharmaceuticals Inc. | 74.51 | 92 | 49 | 77 | 90 | 65 |
| Sionna Therapeutics, Inc. | 37.60 | 44 | 26 | 8 | 62 | 48 |
| OptimizeRx Corporation | 58.71 | 54 | 86 | 42 | 62 | 49 |
| Sutro Biopharma, Inc. | 39.16 | 0 | 35 | 31 | 93 | 38 |
| Korro Bio, Inc. | 31.00 | 37 | 34 | 25 | 31 | 27 |
| ALX Oncology Holdings Inc. | 43.76 | 39 | 52 | 37 | 44 | 47 |
Similar-sized companies in the same sector, this week. P Price · E Earnings · N Nitro · T Torque · A Anchor.
Details
PPrice
| P/E ratio | 0.99 |
| P/B ratio | 0.53 |
EEarnings
| Trailing EPS | ₹391.17 |
| Forward EPS | ₹-7.58 |
NNitro
| Price | 385.49 |
| 52-week high | 518.09 |
| 52-week low | 197.95 |
| Fall from 52-week high | 25.6% |
TTorque
| Return on equity (ROE) | 74.24% |
| Debt-to-equity | 0.00 |
AAnchor
| Beta (price swings) | 1.28 |
| Market cap | ₹1,603 Cr |
| Insider holding | 21.27% |
| Dividend yield | 5.99% |
Figures as used for the week of 17 Oct 2026; today's figures on the company page may differ slightly.
Questions
What is Oramed Pharmaceuticals Inc.'s PosiPenta score?
Oramed Pharmaceuticals Inc.'s PosiPenta is 74.51 out of 100 for the week of 17 Oct 2026, based on 5 of 5 pillars.
Where does Oramed Pharmaceuticals Inc. stand on the Penta Grid?
On the Penta Grid this week, Oramed Pharmaceuticals Inc. is Grid #3 of 837 in the Healthcare sector in United States, and Grid #10 of 4,000 in United States.
Which PosiPenta pillar is strongest for Oramed Pharmaceuticals Inc.?
Price (valuation), with a score of 92 out of 100: much better than most similar companies.
Which PosiPenta pillar is weakest for Oramed Pharmaceuticals Inc.?
Earnings (growth), with a score of 49 out of 100: around the middle of similar companies.
Has Oramed Pharmaceuticals Inc.'s PosiPenta changed since last week?
Yes, it rose 0.74 points, from 73.77 to 74.51.
PositoAI is for research and education only and is not investment advice.